Recent work has suggested that interferons, interferon-stimulated genes, and chemokines such as IP-10 may orchestrate downstream adaptive immunity and influence vaccine effectiveness in SLE patients [19,20,24]. Here, CXCL10 is linked to systemic lupus erythematosus.